Glymidine sodium

Glymidine sodium (INN, also known as glycodiazine; trade name Gondafon) is a sulfonamide antidiabetic drug, structurally related to the sulfonylureas. It was first reported in 1964, and introduced to clinical use in Europe in the mid to late 1960s.[1]

Glycodiazine
Clinical data
Routes of
administration		Oral
ATC code
Pharmacokinetic data
BioavailabilityHigh
Protein binding90%
Elimination half-life3.8 hours
Identifiers
  • N-[5-(2-methoxyethoxy)pyrimidin-2-yl]benzenesulfonamide
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEBI
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard100.005.842
Chemical and physical data
FormulaC13H15N3O4S
Molar mass309.34 g·mol−1
3D model (JSmol)
  • O=S(=O)(Nc1ncc(OCCOC)cn1)c2ccccc2
  • InChI=1S/C13H15N3O4S/c1-19-7-8-20-11-9-14-13(15-10-11)16-21(17,18)12-5-3-2-4-6-12/h2-6,9-10H,7-8H2,1H3,(H,14,15,16) checkY
  • Key:QFWPJPIVLCBXFJ-UHFFFAOYSA-N checkY
 ☒NcheckY (what is this?)  (verify)

References
  1. "Glymidine". British Medical Journal. 2 (5555): 817. June 1967. doi:10.1136/bmj.2.5555.817. PMC 1843097. PMID 6029147.
This article is issued from Wikipedia. The text is licensed under Creative Commons - Attribution - Sharealike. Additional terms may apply for the media files.